About Retatrutide
Retatrutide is studied as a multi-receptor agonist targeting GIP, GLP-1, and glucagon receptors, and is used in laboratory research focused on complex metabolic signaling. It is supplied as a lyophilized powder for investigations into receptor pharmacology, energy metabolism pathways, and glucose regulation mechanisms in controlled experimental models. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99 (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial.
Recent research on Retatrutide: Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial.
Read Full Study on PubMedEngineered nutrient-stimulated hormonal multi-agonist for precision targeting of obesity and metabolic disorders.
Recent research on Retatrutide: Engineered nutrient-stimulated hormonal multi-agonist for precision targeting of obesity and metabolic disorders.
Read Full Study on PubMedAdditional Studies
Gastrointestinal Adverse Effects of Anti-Obesity Medications in Non-Diabetic Adults: A Systematic Review.
Recent research on Retatrutide: Gastrointestinal Adverse Effects of Anti-Obesity Medications in Non-Diabetic Adults: A Systematic Review.
Read on PubMedMedical Management of Obesity: A Comprehensive Review of Food and Drug Administration (FDA)-Approved and Investigational Therapies.
Recent research on Retatrutide: Medical Management of Obesity: A Comprehensive Review of Food and Drug Administration (FDA)-Approved and Investigational Therapies.
Read on PubMedRETRACTED: Retatrutide and Ketoacidosis: Previously Unreported Adverse Effect of the New Triple Agent.
Recent research on Retatrutide: RETRACTED: Retatrutide and Ketoacidosis: Previously Unreported Adverse Effect of the New Triple Agent.
Read on PubMedRelated Research
Purchase Retatrutide from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.